Free Trial

abrdn Healthcare Investors (NYSE:HQH) Short Interest Up 109.3% in August

abrdn Healthcare Investors logo with Finance background

Key Points

  • The short interest in abrdn Healthcare Investors (NYSE:HQH) rose by 109.3% in August, increasing to 128,500 shares compared to 61,400 shares previously.
  • Institutional investors own approximately 32.60% of abrdn Healthcare Investors, with notable additions from firms like Geneos Wealth Management Inc. and US Bancorp DE.
  • The company announced a quarterly dividend of $0.51 per share, yielding 12.2%, with the payment scheduled for September 30th.
  • Five stocks to consider instead of abrdn Healthcare Investors.

abrdn Healthcare Investors (NYSE:HQH - Get Free Report) was the target of a large increase in short interest in August. As of August 31st, there was short interest totaling 128,500 shares, an increase of 109.3% from the August 15th total of 61,400 shares. Approximately 0.3% of the company's stock are sold short. Based on an average daily volume of 203,300 shares, the short-interest ratio is presently 0.6 days. Based on an average daily volume of 203,300 shares, the short-interest ratio is presently 0.6 days. Approximately 0.3% of the company's stock are sold short.

Institutional Investors Weigh In On abrdn Healthcare Investors

Large investors have recently added to or reduced their stakes in the stock. Newbridge Financial Services Group Inc. bought a new position in shares of abrdn Healthcare Investors during the second quarter valued at approximately $34,000. Costello Asset Management INC bought a new position in shares of abrdn Healthcare Investors during the first quarter valued at approximately $40,000. Geneos Wealth Management Inc. grew its stake in shares of abrdn Healthcare Investors by 9,232.3% during the second quarter. Geneos Wealth Management Inc. now owns 2,893 shares of the financial services provider's stock valued at $45,000 after buying an additional 2,862 shares during the last quarter. Colonial Trust Advisors bought a new position in shares of abrdn Healthcare Investors during the second quarter valued at approximately $57,000. Finally, US Bancorp DE grew its stake in shares of abrdn Healthcare Investors by 192.8% during the first quarter. US Bancorp DE now owns 3,733 shares of the financial services provider's stock valued at $61,000 after buying an additional 2,458 shares during the last quarter. 32.60% of the stock is owned by institutional investors.

abrdn Healthcare Investors Stock Performance

Shares of HQH traded down $0.15 during trading hours on Friday, hitting $16.69. The stock had a trading volume of 103,418 shares, compared to its average volume of 185,767. abrdn Healthcare Investors has a 12 month low of $13.77 and a 12 month high of $19.24. The stock has a fifty day moving average price of $16.17 and a 200 day moving average price of $15.91.

abrdn Healthcare Investors Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 30th. Stockholders of record on Friday, August 22nd will be given a $0.51 dividend. This represents a $2.04 annualized dividend and a dividend yield of 12.2%. The ex-dividend date is Friday, August 22nd.

abrdn Healthcare Investors Company Profile

(Get Free Report)

Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in abrdn Healthcare Investors Right Now?

Before you consider abrdn Healthcare Investors, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and abrdn Healthcare Investors wasn't on the list.

While abrdn Healthcare Investors currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.